Online citations, reference lists, and bibliographies.

Understanding On Neuroimmunology In Autism Spectrum Disorder

Amaicha Mara Depino, M A Robinson-Agramonte
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Autism spectrum disorders (ASD) are a group of severe pervasive neurodevelopmental disorders (PDD) affecting between 1 and 3 % of pediatric populations. It is characterized by a highly variable impairment in social interaction and verbal and nonverbal communication, as well as by a stereotyped repetitive behavior, learning problems, and aloofness. ASD behavioral symptoms are frequently accompanied by immunological derangements, including cellular immune dysregulation, chronic inflammatory states, and neuroimmune alterations. Currently, the involvement of the immune pathology in autism remains unclear, and we consider that a better understanding would be useful for earlier clinical and therapeutic interventions. The main aim of this chapter is to review the most current aspects regarding the etiology of autism, with particular reference to the contribution of inflammatory events occurring in the periphery and into the brain, and how they can influence the abnormal development of the offspring and modulate the typical behaviors frequently observed in autism.
This paper references
10.1371/journal.pone.0020470
Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders
K. Suzuki (2011)
10.1177/1073858406296401
The Neurodevelopmental Impact of Prenatal Infections at Different Times of Pregnancy: The Earlier the Worse?
U. Meyer (2007)
10.1073/pnas.0800928105
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR
S. Sauer (2008)
10.1111/j.1469-7610.1987.tb00677.x
Whole blood serotonin in autistic and normal subjects.
G. Anderson (1987)
10.1007/978-3-319-26133-1
B Cell Receptor Signaling
黒崎 知博 (2015)
10.1097/MPG.0b013e3181dcc4a5
Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First-degree Relatives
L. de Magistris (2010)
10.1016/J.RIDD.2005.03.003
Neurochemical correlates of autistic disorder: a review of the literature.
K. S. Lam (2006)
10.1067/MPD.2001.111323
Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism.
R. Furlano (2001)
10.1038/nrn920
Excitatory actions of gaba during development: the nature of the nurture
Y. Ben-Ari (2002)
10.1097/01.CCM.0000191278.04636.D8
Macrophage migration inhibitory factor.
J. Baugh (2002)
10.1182/BLOOD-2004-01-0107
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow.
A. Bernardo (2004)
10.2174/1389203711209070602
Involvement of dietary bioactive proteins and peptides in autism spectrum disorders.
D. Siniscalco (2013)
10.1016/S0006-3223(02)01430-0
Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices
S. Fatemi (2002)
10.4049/jimmunol.1102241
Fyn Promotes Th17 Differentiation by Regulating the Kinetics of RORγt and Foxp3 Expression
A. Ueda (2012)
10.1086/341914
Gastrointestinal microflora studies in late-onset autism.
S. Finegold (2002)
10.1016/j.neulet.2010.01.033
Low-grade endotoxemia in patients with severe autism
E. Emanuele (2010)
10.1038/ni.1939
S1P1-mTOR axis directs the reciprocal differentiation of TH1 and regulatory T cells
G. Liu (2010)
10.1289/ehp.8483
The CHARGE Study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism
I. Hertz-Picciotto (2006)
10.1523/JNEUROSCI.2298-06.2006
Maternal Infection and the Offspring Brain
A. Depino (2006)
10.1016/S0022-510X(99)00072-6
Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis
S. Pradhan (1999)
10.1007/BF01531564
Autism in a child with congenital cytomegalovirus infection
P. I. Markowitz (1983)
10.1016/j.pnpbp.2006.08.020
Decreased serum levels of transforming growth factor-β1 in patients with autism
K. Okada (2007)
10.1089/cap.2009.0071
Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene.
P. Hoekstra (2010)
10.1159/000054275
Passage of Interleukin-1-Beta Across the Blood-Brain Barrier Is Reduced in Aged Mice: A Possible Mechanism for Diminished Fever in Aging
R. McLay (2000)
10.1016/j.bbi.2012.07.008
Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development
Paula A. Garay (2013)
10.1523/JNEUROSCI.19-12-j0002.1999
GATA-3 Is Involved in the Development of Serotonergic Neurons in the Caudal Raphe Nuclei
J. Hikke van Doorninck (1999)
10.1016/j.jneuroim.2005.12.007
Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms
P. Ashwood (2006)
10.1016/J.COI.2006.03.017
Expanding the effector CD4 T-cell repertoire: the Th17 lineage.
L. Harrington (2006)
10.1023/A:1025023131029
Possible Association Between Congenital Cytomegalovirus Infection and Autistic Disorder
Y. Yamashita (2003)
10.1016/j.anaerobe.2011.12.018
Microbiology of regressive autism.
S. Finegold (2012)
10.1001/archpsyc.1977.01770170031002
Hyperserotonemia and amine metabolites in autistic and retarded children.
H. Hanley (1977)
10.1016/J.MEHY.2006.10.015
Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders.
J. Bradstreet (2007)
10.1093/hmg/ddr337
A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.
I. Rodríguez-Escudero (2011)
10.1186/2040-2392-1-7
Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry
I. Sousa (2010)
10.1016/S0165-5728(98)00021-6
Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism
S. Gupta (1998)
10.1016/0006-3223(87)90002-3
Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects
R. Minderaa (1987)
10.1016/J.YGENO.2007.09.003
Gene expression changes in children with autism.
J. Gregg (2008)
10.1007/s00439-006-0301-3
Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels
A. Coutinho (2006)
10.1023/A:1013238809666
Density and Distribution of Hippocampal Neurotransmitter Receptors in Autism: An Autoradiographic Study
G. Blatt (2001)
10.1210/en.2012-1435
Brain meets body: the blood-brain barrier as an endocrine interface.
W. Banks (2012)
10.1111/j.1572-0241.2000.03248.x
Enterocolitis in children with developmental disorders
A. Wakefield (2000)
10.1186/1742-2094-5-52
Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study
H. Jyonouchi (2008)
10.1016/j.bbi.2010.08.003
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome
P. Ashwood (2011)
10.1016/J.PEDIATRNEUROL.2006.06.006
HLA-DR4 in families with autism.
L. Lee (2006)
10.1111/j.1749-6632.2010.05742.x
Anti-inflammatory functions of the "apoptotic" caspases.
David Wallach (2010)
10.1099/JMM.0.46101-0
Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children.
Helena Parracho (2005)
10.1189/jlb.1205707
The immune response in autism: a new frontier for autism research
P. Ashwood (2006)
10.1542/peds.2009-1878C
Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report
T. Buie (2010)
10.1016/j.jaac.2010.03.015
Identifying loci for the overlap between attention-deficit/hyperactivity disorder and autism spectrum disorder using a genome-wide QTL linkage approach.
J. Nijmeijer (2010)
10.1016/j.bbi.2009.08.001
Differential monocyte responses to TLR ligands in children with autism spectrum disorders
A. Enstrom (2010)
10.1002/ajmg.a.31619
Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly
G. Herman (2007)
10.1007/BF01531729
Immune abnormalities in patients with autism
R. P. Warren (1986)
10.1097/00004703-200604002-00010
Early Medical History of Children with Autism Spectrum Disorders
Rebecca Niehus (2006)
10.1136/jmg.2004.024646
Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations
M. Butler (2005)
10.1523/JNEUROSCI.13-08-03574.1993
Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus
F. Shintani (1993)
10.1007/S10803-006-0131-0
Patterns of Complementary and Alternative Medical Therapy Use in Children Diagnosed with Autism Spectrum Disorders
H. Wong (2006)
10.1016/S0022-3476(61)80261-8
Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.
R. Schain (1961)
10.1023/A:1022827417414
Decreased Expression of CD95 (FAS/APO-1) on CD4+ T-lymphocytes from Participants with Autism
H. Engstrom (2003)
10.1001/archneur.1981.00510030085013
Acquired reversible autistic syndrome in acute encephalopathic illness in children.
G. Delong (1981)
10.1016/j.nicl.2013.06.015
Atypical excitation–inhibition balance in autism captured by the gamma response to contextual modulation☆
T. M. Snijders (2013)
10.1111/J.1753-4887.2007.TB00362.X
Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury.
R. Romero (2007)
10.1038/sj.mp.4001077
Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism
F. Torrente (2002)
10.1111/j.1600-065X.2008.00705.x
The interleukin‐23 axis in intestinal inflammation
Philip P. Ahern (2008)
10.1016/J.MEHY.2007.08.016
Autism and vitamin D.
J. Cannell (2008)
10.1016/j.immuni.2012.06.020
The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells.
Thomas Hoyler (2012)
10.1016/S0074-7742(05)71013-8
Immunological findings in autism.
H. Cohly (2005)
10.1177/039463200301600302
Infections, Toxic Chemicals and Dietary Peptides Binding to Lymphocyte Receptors and Tissue Enzymes are Major Instigators of Autoimmunity in Autism
A. Vojdani (2003)
10.1007/S10803-006-0100-7
Hyperserotoninemia and Altered Immunity in Autism
Nancy K Burgess (2006)
10.1002/HIPO.10164
Learning modulation by endogenous hippocampal IL‐1: Blockade of endogenous IL‐1 facilitates memory formation
A. Depino (2004)
10.1016/J.PEDIATRNEUROL.2007.01.012
Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children.
M. Chez (2007)
10.1016/j.ejphar.2011.07.013
Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management.
C. G. M. de Theije (2011)
10.1523/JNEUROSCI.0099-06.2006
The Time of Prenatal Immune Challenge Determines the Specificity of Inflammation-Mediated Brain and Behavioral Pathology
U. Meyer (2006)
10.1016/j.jneuroim.2005.11.007
Elevated cytokine levels in children with autism spectrum disorder
C. Molloy (2006)
10.1016/j.tins.2009.11.003
mTOR signaling: At the crossroads of plasticity, memory and disease
C. Hoeffer (2010)
10.1111/j.1600-0897.2009.00791.x
ORIGINAL ARTICLE: The Transcriptome of the Fetal Inflammatory Response Syndrome
Sally A Madsen-Bouterse (2010)
10.1093/HUMREP/DEL178
Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I : C).
V. Abrahams (2006)
10.1111/j.1365-2796.2008.01950.x
The Interleukin‐23 / Interleukin‐17 axis in intestinal inflammation
K. Maloy (2008)
10.3109/15622970209150618
Treatment of Late Onset Autism as a Consequence of Probable Autommune Processes Related to Chronic Bacterial Infection
E. B. Matarazzo (2002)
10.1016/0024-3205(91)90040-I
Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo.
P. S. MohanKumar (1991)
10.1016/S1081-1206(10)62426-X
T-cell subsets (Th1 versus Th2).
S. Romagnani (2000)
10.1023/B:JOCI.0000010427.05143.bb
Intestinal Lymphocyte Populations in Children with Regressive Autism: Evidence for Extensive Mucosal Immunopathology
P. Ashwood (2004)
10.1542/peds.2012-0900N
Gastrointestinal Conditions in Children With Autism Spectrum Disorder: Developing a Research Agenda
D. Coury (2012)
10.1016/J.MEHY.2004.11.018
The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity.
M. Geier (2005)
Epidemiology of autistic disorder and other pervasive developmental disorders.
E. Fombonne (2005)
10.1001/ARCHPSYC.1996.01830110029004
Effects of tryptophan depletion in drug-free adults with autistic disorder.
C. McDougle (1996)
10.1016/j.mcn.2012.10.003
Peripheral and central inflammation in autism spectrum disorders
A. Depino (2013)
10.1159/000330247
Neuroinflammation: A Common Pathway in CNS Diseases as Mediated at the Blood-Brain Barrier
M. Erickson (2012)
10.1111/j.1651-2227.1996.tb14220.x
Abnormal intestinal permeability in children with autism
P. D’Eufemia (1996)
10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9
Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children
D. Chugani (1999)
10.1542/peds.2007-3604
Macrophage Migration Inhibitory Factor and Autism Spectrum Disorders
E. Grigorenko (2008)
10.1089/cap.2009.0022
Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability.
L. E. Arnold (2010)
10.1016/S0006-8993(97)00312-0
Effects of interleukin-1β and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study
Z. Merali (1997)
10.7326/0003-4819-126-9-199705010-00008
Intravenous Immune Globulin Therapy for Neurologic Diseases
M. Dalakas (1997)
10.1159/000119172
DR-positive T cells in autism: association with decreased plasma levels of the complement C4B protein.
R. P. Warren (1995)
10.1007/s10803-009-0714-7
Complementary Alternative Medicine for Children with Autism: A Physician Survey
Allison Golnik (2009)
10.1016/j.anaerobe.2011.03.007
State of the art; microbiology in health and disease. Intestinal bacterial flora in autism.
S. Finegold (2011)
10.1177/088307380001500701
Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
R. Sandler (2000)
10.1016/j.jneuroim.2009.09.005
Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders
C. Onore (2009)
10.1016/j.bbi.2011.05.007
Early and adult hippocampal TGF-β1 overexpression have opposite effects on behavior
A. Depino (2011)
10.1016/J.NBD.2005.01.017
Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus
M. A. Ray (2005)
10.1007/s10803-011-1373-z
The Expression of Caspases is Enhanced in Peripheral Blood Mononuclear Cells of Autism Spectrum Disorder Patients
D. Siniscalco (2012)
10.1016/J.COI.2007.07.020
Th17: the third member of the effector T cell trilogy.
E. Bettelli (2007)
10.1007/BF01531665
Brief report: Onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis
C. Gillberg (1986)
10.1182/blood-2012-02-409722
Generation of Th17 from human naive CD4+ T cells preferentially occurs from FOXP3+ Tregs upon costimulation via CD28 or CD5.
M. Ayyoub (2012)
10.1016/j.neuron.2009.09.002
Cytokines and CNS Development
B. Deverman (2009)
10.1002/ana.20315
Neuroglial activation and neuroinflammation in the brain of patients with autism
D. L. Vargas (2005)
10.1189/jlb.1206756
Caspase‐1 inflammasomes in infection and inflammation
M. Lamkanfi (2007)
10.1016/S0887-8994(02)00627-6
Elevated levels of measles antibodies in children with autism.
V. Singh (2003)
10.1002/glia.1104
Glial cell influence on the human blood‐brain barrier
A. Prat (2001)
10.1016/S0074-7742(05)71001-1
Autism: neuropathology, alterations of the GABAergic system, and animal models.
C. Schmitz (2005)
10.1016/0165-5728(96)00014-8
Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism
V. Singh (1996)
10.1038/nrn919
Is there more to gaba than synaptic inhibition?
D. F. Owens (2002)
10.1016/J.HUMIMM.2006.01.001
The association and linkage of the HLA-A2 class I allele with autism.
A. Torres (2006)
10.1111/j.1750-3639.2007.00102.x
The Neurobiology of Autism
C. Pardo (2007)
10.1080/02646830500381930
Immunity, neuroglia and neuroinflammation in autism
C. Pardo (2005)
10.1016/j.bbr.2010.10.005
Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder
D. MacFabe (2011)
10.1146/ANNUREV.NE.18.030195.000533
The neurobiology of infantile autism.
A. L. Ciaranello (1995)
10.1016/j.immuni.2012.08.015
The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells.
J. Mjösberg (2012)
10.1371/journal.pone.0068322
Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children
Dae-Wook Kang (2013)
10.1023/A:1022669125423
Autistic Subjects with Comorbid Epilepsy: A Possible Association with Viral Infections
Y. Barak (1999)
10.1016/S0166-2236(00)02088-9
Cytokine-induced sickness behaviour: mechanisms and implications
J. Konsman (2002)
10.1159/000119223
Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism.
W. W. Daniels (1995)
10.1159/000111642
Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological.
J. Merrill (1992)
10.1007/BF02211849
A case study of the cognitive and behavioral deficits of temporal lobe damage in herpes simplex encephalitis
Margaret K. Greer (1989)
10.1007/BF01537741
Autism in children with congenital rubella
S. Chess (1971)
10.1111/j.1600-0447.1993.tb03378.x
Serotonin and amino acid content in platelets of autistic children
L. Rolf (1993)
10.1001/JAMA.285.24.3093
Pervasive developmental disorders in preschool children.
S. Chakrabarti (2001)
10.1159/000084164
Dysregulated Innate Immune Responses in Young Children with Autism Spectrum Disorders: Their Relationship to Gastrointestinal Symptoms and Dietary Intervention
H. Jyonouchi (2005)
10.1007/s10803-010-1006-y
Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders
H. Atladóttir (2010)
10.1038/mp.2008.21
Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression
C. Lintas (2009)
10.1016/j.anaerobe.2010.06.008
Pyrosequencing study of fecal microflora of autistic and control children.
S. Finegold (2010)
10.1016/J.SMIM.2007.02.008
mTOR at the crossroads of T cell proliferation and tolerance.
A. Mondino (2007)
Th1/Th2 cells, their associated molecules and role in pathophysiology.
P. Romagnani (2000)
10.1097/00004703-200312000-00003
Use of Complementary and Alternative Medicine Among Children Recently Diagnosed with Autistic Spectrum Disorder
S. Levy (2003)
10.1016/j.jneuroim.2008.07.006
Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomes
P. Ashwood (2008)
10.1016/S0893-133X(96)00057-7
Seasonal Variation in Neuroendocrine and Mood Responses to IV L-Tryptophan in Depressed Patients and Healthy Subjects
A. Cappiello (1996)
10.1016/j.imbio.2010.03.001
Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects.
M. Malik (2011)
10.1177/088307389901400608
Familial Clustering of Autoimmune Disorders and Evaluation of Medical Risk Factors in Autism
A. Comi (1999)
10.1146/ANNUREV.IMMUNOL.16.1.137
REGULATION OF IMMUNE RESPONSES BY TGF-β*
J. Letterio (1998)
10.1371/journal.pone.0035572
Inflammation-Driven Reprogramming of CD4+Foxp3+ Regulatory T Cells into Pathogenic Th1/Th17 T Effectors Is Abrogated by mTOR Inhibition in vivo
E. Yurchenko (2012)
10.1016/j.nbd.2008.01.012
Immune transcriptome alterations in the temporal cortex of subjects with autism
K. Garbett (2008)
10.1038/sj.mp.4001714
Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene–environment interactions
M. D’Amelio (2005)
10.1007/BF02216053
Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4–9), in 14 outpatient autistic children
J. Buitelaar (1990)
10.1016/j.neubiorev.2004.11.003
Prenatal origins of individual variation in behavior and immunity
C. Coe (2005)
10.1007/s10803-008-0646-7
GABAA Receptor Downregulation in Brains of Subjects with Autism
S. Fatemi (2009)
10.1023/A:1013234708757
Dysregulation of Reelin and Bcl-2 Proteins in Autistic Cerebellum
S. Fatemi (2001)
10.3389/neuro.08.014.2009
Early-Life Programming of Later-Life Brain and Behavior: A Critical Role for the Immune System
S. Bilbo (2009)
10.1186/1471-230X-11-22
Gastrointestinal flora and gastrointestinal status in children with autism -- comparisons to typical children and correlation with autism severity
J. Adams (2011)
10.1016/j.jaut.2009.11.007
Coordination of tolerogenic immune responses by the commensal microbiota.
J. Round (2010)
10.1016/j.bbi.2011.09.003
Amniotic fluid chemokines and autism spectrum disorders: An exploratory study utilizing a Danish Historic Birth Cohort
M. Abdallah (2012)
10.1176/APPI.AJP.162.6.1133
Pervasive developmental disorders in preschool children: confirmation of high prevalence.
S. Chakrabarti (2005)
10.1007/S11894-002-0071-6
Autism and gastrointestinal symptoms
K. Horváth (2002)
10.1067/MPD.2000.105355
Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.
S. Shenoy (2000)
10.1002/ajmg.b.30947
Autistic traits in simplex and multiplex autism families: Focus on unaffected relatives
R. Hoekstra (2010)
10.1016/S0928-4680(97)00168-5
Evidence for an infectious etiology in autism
A. Ring (1997)
10.1177/0883073809339393
Frequency of CD4+CD25high Regulatory T Cells in the Peripheral Blood of Egyptian Children With Autism
G. Mostafa (2010)
10.1016/j.jneuroim.2008.12.002
Elevated immune response in the brain of autistic patients
X. Li (2009)
10.1038/ejhg.2010.69
Linkage and candidate gene studies of autism spectrum disorders in European populations
R. Holt (2010)
10.1542/peds.2006-1788
Infection in the First 2 Years of Life and Autism Spectrum Disorders
N. Rosen (2007)
10.1016/j.neures.2009.02.009
Common increase of GATA-3 level in PC-12 cells by three teratogens causing autism spectrum disorders
U. Rout (2009)
10.1084/jem.20070602
Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid
Cheng-ming Sun (2007)
10.1055/s-2008-1071471
Autism as one of several disabilities in two children with congenital cytomegalovirus infection.
S. Ivarsson (1990)
10.1007/BF02409660
Autism and congenital cytomegalovirus
E. Stubbs (1984)
10.1007/BF01550276
Autistic symptoms in a child with congenital cytomegaloviras infection
E. Stubbs (1978)
10.1007/BF01046406
Brief report: Autism and herpes simplex encephalitis
M. Ghaziuddin (1992)
10.1042/BST0351508
A phylogenetic and functional overview of inflammatory caspases and caspase-1-related CARD-only proteins.
K. Kersse (2007)
10.1093/schbul/sbn022
A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.
U. Meyer (2009)
10.1038/nri2295
TH17 cells in development: an updated view of their molecular identity and genetic programming
C. Dong (2008)
Treatment of children with autism with intravenous immunoglobulin.
S. Gupta (1999)
10.1002/aur.1338
Altered Peripheral and Central Inflammatory Responses in a Mouse Model of Autism
Luciana Lucchina (2014)
10.1111/J.1469-7610.1997.TB01518.X
Autism and the immune system.
T. van Gent (1997)
10.1177/088307389801300207
Intravenous Immunoglobulin Treatment of Children With Autism
A. Plioplys (1998)
10.1189/jlb.0703347
Receptor tyrosine kinases and the regulation of macrophage activation
P. Correll (2004)
10.1542/PEDS.112.4.939
Constipation with acquired megarectum in children with autism.
N. Afzal (2003)
10.1093/BRAIN/AWF160
Nicotinic receptor abnormalities in the cerebellar cortex in autism.
M. Lee (2002)
10.1016/J.MOLBRAINRES.2004.01.003
Molecular analysis of nicotinic receptor expression in autism.
C. Martín-Ruiz (2004)
10.1007/s12311-008-0075-3
Expression of GABAB Receptors Is Altered in Brains of Subjects with Autism
S. Fatemi (2008)
10.1126/science.1219328
Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function
Torsten Olszak (2012)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar